Talaris Therapeutics Inc - ESG Rating & Company Profile powered by AI
This ESG score for Talaris Therapeutics Inc indicates its transparency towards the UN SDGs. This article contains a questions and answers section about Talaris Therapeutics Inc. This assessment of Talaris Therapeutics Inc is assembled by All Street Sevva using proprietary AI.
Talaris Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.0, social score of 6.4 and governance score of 4.8.
4.4
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
868 | Trevena Inc | 4.5 | High |
868 | Urogen Pharma Ltd | 4.5 | High |
910 | Talaris Therapeutics Inc | 4.4 | High |
910 | CanBas Co Ltd | 4.4 | High |
910 | CNS Pharmaceuticals Inc | 4.4 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Talaris Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Talaris Therapeutics Inc disclose current and historical energy intensity?
Does Talaris Therapeutics Inc report the average age of the workforce?
Does Talaris Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Talaris Therapeutics Inc disclose its ethnicity pay gap?
Does Talaris Therapeutics Inc disclose cybersecurity risks?
Does Talaris Therapeutics Inc offer flexible work?
Does Talaris Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Talaris Therapeutics Inc disclose the number of employees in R&D functions?
Does Talaris Therapeutics Inc conduct supply chain audits?
Does Talaris Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Talaris Therapeutics Inc conduct 360 degree staff reviews?
Does Talaris Therapeutics Inc disclose the individual responsible for D&I?
Does Talaris Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Talaris Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Talaris Therapeutics Inc disclose water use targets?
Does Talaris Therapeutics Inc have careers partnerships with academic institutions?
Did Talaris Therapeutics Inc have a product recall in the last two years?
Does Talaris Therapeutics Inc disclose incidents of discrimination?
Does Talaris Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Talaris Therapeutics Inc issued a profit warning in the past 24 months?
Does Talaris Therapeutics Inc disclose parental leave metrics?
Does Talaris Therapeutics Inc disclose climate scenario or pathway analysis?
Does Talaris Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Talaris Therapeutics Inc disclose the pay ratio of women to men?
Does Talaris Therapeutics Inc support suppliers with sustainability related research and development?
Does Talaris Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Talaris Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Talaris Therapeutics Inc involved in embryonic stem cell research?
Does Talaris Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Talaris Therapeutics Inc disclose its waste policy?
Does Talaris Therapeutics Inc report according to TCFD requirements?
Does Talaris Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Talaris Therapeutics Inc disclose energy use targets?
Does Talaris Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Talaris Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Talaris Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.